Entity Details

Primary name S17A9_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionQ9BYT1
EntryNameS17A9_HUMAN
FullNameSolute carrier family 17 member 9
TaxID9606
Evidenceevidence at protein level
Length436
SequenceStatuscomplete
DateCreated2004-05-24
DateModified2021-06-02

Ontological Relatives

GenesSLC17A9

GO terms

Show/Hide Table
GOName
GO:0001409 guanine nucleotide transmembrane transporter activity
GO:0005347 ATP transmembrane transporter activity
GO:0006887 exocytosis
GO:0015217 ADP transmembrane transporter activity
GO:0015866 ADP transport
GO:0015867 ATP transport
GO:0016021 integral component of membrane
GO:0042584 chromaffin granule membrane
GO:1903790 guanine nucleotide transmembrane transport
GO:1904669 ATP export

Subcellular Location

Show/Hide Table
Subcellular Location
Membrane

Domains

Show/Hide Table
DomainNameCategoryType
IPR005829 Sugar transporter, conserved siteSiteConserved site
IPR011701 Major facilitator superfamilyFamilyFamily
IPR020846 Major facilitator superfamily domainDomainDomain
IPR036259 MFS transporter superfamilyFamilyHomologous superfamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
616063 OMIMPorokeratosis 8, disseminated superficial actinic type (POROK8)A form of porokeratosis, a disorder of faulty keratinization characterized by one or more atrophic patches surrounded by a distinctive hyperkeratotic ridgelike border called the cornoid lamella. The keratotic lesions can progress to overt cutaneous neoplasms, typically squamous cell carcinomas. Multiple clinical variants of porokeratosis are recognized, including porokeratosis of Mibelli, linear porokeratosis, disseminated superficial actinic porokeratosis, palmoplantar porokeratosis, and punctate porokeratosis. Disseminated superficial actinic porokeratosis (DSAP) is the most common subtype. It is characterized by multiple small, annular, anhidrotic, keratotic lesions that are located predominantly on sun-exposed areas of the skin, such as the face, neck, and distal limbs. The lesions typically begin to develop in adolescence and reach near-complete penetrance by the third or fourth decade of life. The disease is caused by variants affecting the gene represented in this entry.

Interactions

7 interactions